Home/Filings/4/0001213900-23-098490
4//SEC Filing

HSU ERIC C 4

Accession 0001213900-23-098490

CIK 0001728328other

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 1:07 PM ET

Size

5.5 KB

Accession

0001213900-23-098490

Insider Transaction Report

Form 4
Period: 2023-12-23
HSU ERIC C
Sr VP, Pre-Clinical Res/Dev
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-12-23+45,00052,854 total
    Exercise: $0.37Exp: 2028-12-22Common shares (45,000 underlying)
Footnotes (1)
  • [F1]The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month).

Documents

1 file

Issuer

InMed Pharmaceuticals Inc.

CIK 0001728328

Entity typeother

Related Parties

1
  • filerCIK 0001817867

Filing Metadata

Form type
4
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 1:07 PM ET
Size
5.5 KB